Scalper1 News
The four highest-rated of the market’s seven big-cap biotechs are set to report second-quarter earnings this week, each with its own unique storyline. Biogen Idec (BIIB), the subject of Tuesday’s New America, will be first to report before the open Wednesday. Analysts’ consensus calls for sales of $2.16 billion, up 25% from the year-earlier quarter, with earnings up 23% to $2.83 a share. One point of interest about the quarter is that it includes Scalper1 News
Scalper1 News